Document Detail


Activation and regulation of toll-like receptor 9: CpGs and beyond.
MedLine Citation:
PMID:  18537714     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Toll-like receptor 9 has been the focus of considerable research attention for the ability to modulate its activity, and subsequent innate immune responses, through DNA-based immunotherapeutics. Nucleic acids are attractive as therapeutics for their low cost, chemical stability and ease of production. While the ability for TLR9 to be differentially regulated by nucleic acids of varying sequences and structures offers flexibility for immunotherapeutic design, it also necessitates a more comprehensive characterization of these agonists in terms of how these structural parameters correlate with the activation of unique cellular responses. Despite the utilization of TLR9 agonists in human trials these issues have not been adequately addressed. While a wealth of cell stimulation experiments demonstrate the preferential ability for nucleic acids which contain unmethylated cytosine-phosphate-guanine (CpG) motifs to initiate innate immune responses this has not been supported by binding investigations from which largely contradictory information has emerged with respect to the ability of TLR9 to bind nucleic acids in a sequence-dependent fashion. Recent models help to reconcile this apparent contradiction by suggesting that while TLR9 activation is specific for CpG-containing nucleic acids, the receptor binds, and is functionally influenced by, nucleic acids in a sequence-independent fashion. We have proposed a model in which the absolute concentration of nucleic acids modulates the sensitivity of the receptor in a sequence-dependent fashion while activation is specifically achieved by CpG-containing ligands. In this review we reconsider the literature from the perspective of this new appreciation of the functional complexity of TLR9 ligand binding and higher-order regulation with discussion of the implications for immunotherapeutic targeting of TLR9.
Authors:
Jason Kindrachuk; Jean Potter; Heather L Wilson; Philip Griebel; Lorne A Babiuk; Scott Napper
Related Documents :
18969304 - Selective labeling of histidine by a designed fluorescein-based probe.
11475694 - Purification of nucleic acids by hybridization to affinity tagged pna probes.
10699844 - Volumetric properties of nucleic acids.
16346114 - Selected nucleic acid precursors in studies of aquatic microbial ecology.
1637724 - Estrogen receptor affinity and effects on mcf-7 cell growth of triarylethylene carboxyl...
7854014 - Peroxidation reactions in plant membranes: effects of free fatty acids.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Review    
Journal Detail:
Title:  Mini reviews in medicinal chemistry     Volume:  8     ISSN:  1389-5575     ISO Abbreviation:  Mini Rev Med Chem     Publication Date:  2008 Jun 
Date Detail:
Created Date:  2008-06-09     Completed Date:  2008-08-18     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101094212     Medline TA:  Mini Rev Med Chem     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  590-600     Citation Subset:  IM    
Affiliation:
Vaccine and Infectious Disease Organization, University of Saskatchewan, Saskatoon, Saskatchewan S7N 5E3, Canada.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
CpG Islands / physiology*
Humans
Models, Biological*
Signal Transduction
Toll-Like Receptor 9 / physiology*
Up-Regulation
Chemical
Reg. No./Substance:
0/Toll-Like Receptor 9

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  A novel mercaptopyruvate sulfurtransferase thioredoxin-dependent redox-sensing molecular switch: a m...
Next Document:  The role of retinoids in the adult nervous system and their therapeutic potential.